• -
  • English
  • Japanese
  • Korean
市場調查報告書
商品編碼
1087251

乾癬治療藥的全球市場:產業分析，趨勢，市場規模，及預測(∼2028年)

Psoriasis Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028
出版日期: | 出版商: Infinium Global Research (IGR) | 英文 100 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球乾癬治療藥的市場規模在2022∼2028年的預測期間中預計將以9％的年複合成長率成長。

本報告提供全球乾癬治療藥市場調查，提供市場概要，市場規模和預測，趨勢，成長要素及阻礙因素，分子類型·給藥途徑·劑量·各地區的分析等全面性資訊。

目錄

第1章 序文

  • 報告的說明
  • 調查方法
  • 研究途徑

第2章 摘要整理

  • 乾癬治療藥市場概況
  • 乾癬治療藥市場預測
  • 乾癬治療藥市場地區的亮點

第3章 全球乾癬治療藥市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 乾癬治療藥市場上COVID-19的影響分析
  • 波特的五力分析
  • IGR-成長矩陣分析
    • IGR-各分子類型的成長矩陣分析
    • IGR-各給藥途徑的成長矩陣分析
    • IGR-各劑量的成長矩陣分析
    • IGR-各地區的成長矩陣分析
  • 乾癬治療藥市場價值鏈分析

第4章 乾癬治療藥市場宏觀指標分析

第5章 全球乾癬治療藥市場:各分子類型

  • 生技藥品
  • 小分子

第6章 全球乾癬治療藥市場:各給藥途徑

  • 口服
  • 非口服
  • 局部

第7章 全球乾癬治療藥市場:各劑量

  • TNF抑制劑
  • PDE4抑制劑
  • 白細胞介素阻滯劑
  • 其他

第8章 全球乾癬治療藥市場:各地區(2022年∼2028年)

  • 北美
    • 各分子類型的北美的乾癬治療藥市場
    • 各給藥途徑的北美的乾癬治療藥市場
    • 各劑量的北美的乾癬治療藥市場
    • 各國北美的乾癬治療藥市場
  • 歐洲
    • 各分子類型的歐洲的乾癬治療藥市場
    • 各給藥途徑的歐洲的乾癬治療藥市場
    • 各劑量的歐洲的乾癬治療藥市場
    • 各國歐洲的乾癬治療藥市場
  • 亞太地區
    • 各分子類型的亞太地區的乾癬治療藥市場
    • 各給藥途徑的亞太地區的乾癬治療藥市場
    • 各劑量的亞太地區的乾癬治療藥市場
    • 各國亞太地區的乾癬治療藥市場
  • 其他地區
    • 各分子類型的其他地區的乾癬治療藥市場
    • 各給藥途徑的其他地區的乾癬治療藥市場
    • 各劑量的其他地區的乾癬治療藥市場
    • 各子地區的其他地區的乾癬治療藥市場

第9章 企業簡介和競爭情形

  • 全球乾癬治療藥市場競爭情形
  • 企業簡介
    • Astellas Pharma Inc.
    • AstraZeneca plc
    • Boehringer Ingelheim GmbH
    • F. Hofffmann-La Roche
    • GlaxoSmithKline plc
    • Merck and Co., Inc.
    • Valeant Pharmaceuticals International, Inc.
    • Biocon Limited
    • Eli Lilly and Company
    • G and W Laboratories Inc.
目錄
Product Code: HC0146

The report on the global psoriasis therapeutics market provides qualitative and quantitative analysis for the period from 2020 to 2028. The report predicts the global psoriasis therapeutics market to grow with a CAGR of 9% over the forecast period from 2022-2028. The study on psoriasis therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2020 to 2028.

The report on psoriasis therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global psoriasis therapeutics market over the period of 2020 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global psoriasis therapeutics market over the period of 2020 to 2028. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Rising incidence of psoriasis with skin disorders
  • Increasing awareness among people

2) Restraints

  • High costs of therapies

3) Opportunities

  • Cumulative development of new biologics and new pipeline drugs

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global psoriasis therapeutics market is segmented on the basis of molecule type, route of administration, and dosage.

The Global Psoriasis Therapeutics Market by Molecule Type

  • Biologics
  • Small Molecules

The Global Psoriasis Therapeutics Market by Route Of Administration

  • Oral
  • Parenteral
  • Topical

The Global Psoriasis Therapeutics Market by Dosage

  • TNF Inhibitors
  • PDE4 Inhibitors
  • Interleukin Blockers
  • Others

Company Profiles

The companies covered in the report include

  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • F. Hofffmann-La Roche
  • GlaxoSmithKline plc
  • Merck and Co., Inc.
  • Valeant Pharmaceuticals International, Inc.
  • Biocon Limited
  • Eli Lilly and Company
  • G and W Laboratories Inc.

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the psoriasis therapeutics market.

2. Complete coverage of all the segments in the psoriasis therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2028.

3. Comprehensive analysis of the companies operating in the global psoriasis therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

2. Executive Summary

  • 2.1. Psoriasis Therapeutics Market Highlights
  • 2.2. Psoriasis Therapeutics Market Projection
  • 2.3. Psoriasis Therapeutics Market Regional Highlights

3. Global Psoriasis Therapeutics Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Analysis of COVID-19 impact on the Psoriasis Therapeutics Market
  • 3.4. Porter's Five Forces Analysis
  • 3.5. IGR-Growth Matrix Analysis
    • 3.5.1. IGR-Growth Matrix Analysis by Molecule Type
    • 3.5.2. IGR-Growth Matrix Analysis by Route of Administration
    • 3.5.3. IGR-Growth Matrix Analysis by Dosage
    • 3.5.4. IGR-Growth Matrix Analysis by Region
  • 3.6. Value Chain Analysis of Psoriasis Therapeutics Market

4. Psoriasis Therapeutics Market Macro Indicator Analysis

5. Global Psoriasis Therapeutics Market by Molecule Type

  • 5.1. Biologics
  • 5.2. Small Molecules

6. Global Psoriasis Therapeutics Market by Route of Administration

  • 6.1. Oral
  • 6.2. Parenteral
  • 6.3. Topical

7. Global Psoriasis Therapeutics Market by Dosage

  • 7.1. TNF Inhibitors
  • 7.2. PDE4 Inhibitors
  • 7.3. Interleukin Blockers
  • 7.4. Others

8. Global Psoriasis Therapeutics Market by Region 2022-2028

  • 8.1. North America
    • 8.1.1. North America Psoriasis Therapeutics Market by Molecule Type
    • 8.1.2. North America Psoriasis Therapeutics Market by Route of Administration
    • 8.1.3. North America Psoriasis Therapeutics Market by Dosage
    • 8.1.4. North America Psoriasis Therapeutics Market by Country
  • 8.2. Europe
    • 8.2.1. Europe Psoriasis Therapeutics Market by Molecule Type
    • 8.2.2. Europe Psoriasis Therapeutics Market by Route of Administration
    • 8.2.3. Europe Psoriasis Therapeutics Market by Dosage
    • 8.2.4. Europe Psoriasis Therapeutics Market by Country
  • 8.3. Asia-Pacific
    • 8.3.1. Asia-Pacific Psoriasis Therapeutics Market by Molecule Type
    • 8.3.2. Asia-Pacific Psoriasis Therapeutics Market by Route of Administration
    • 8.3.3. Asia-Pacific Psoriasis Therapeutics Market by Dosage
    • 8.3.4. Asia-Pacific Psoriasis Therapeutics Market by Country
  • 8.4. RoW
    • 8.4.1. RoW Psoriasis Therapeutics Market by Molecule Type
    • 8.4.2. RoW Psoriasis Therapeutics Market by Route of Administration
    • 8.4.3. RoW Psoriasis Therapeutics Market by Dosage
    • 8.4.4. RoW Psoriasis Therapeutics Market by Sub-region

9. Company Profiles and Competitive Landscape

  • 9.1. Competitive Landscape in the Global Psoriasis Therapeutics Market
  • 9.2. Companies Profiles
    • 9.2.1. Astellas Pharma Inc.
    • 9.2.2. AstraZeneca plc
    • 9.2.3. Boehringer Ingelheim GmbH
    • 9.2.4. F. Hofffmann-La Roche
    • 9.2.5. GlaxoSmithKline plc
    • 9.2.6. Merck and Co., Inc.
    • 9.2.7. Valeant Pharmaceuticals International, Inc.
    • 9.2.8. Biocon Limited
    • 9.2.9. Eli Lilly and Company
    • 9.2.10. G and W Laboratories Inc.